The global Hereditary Testing market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Myriad Genetics, Inc.
CooperSurgical, Inc.
Natera, Inc.
Invitae Corporation
Quest Diagnostics Incorporated
Illumina, Inc.
Thermo Fisher Scientific, Inc.
F. Hoffmann-La Roche Ltd
Laboratory Corporation of America Holdings
Agilent Technologies, Inc.
CENTOGENE
Twist Bioscience
Medgenome
Sophia Genetics
Fulgent Genetic, Inc.
By Types:
Hereditary Cancer Testing
Hereditary Non-cancer Testing
By Applications:
Hospital
Clinic
Laboratory
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Hereditary Testing Market Size Analysis from 2023 to 2028
1.5.1 Global Hereditary Testing Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Hereditary Testing Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Hereditary Testing Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Hereditary Testing Industry Impact
Chapter 2 Global Hereditary Testing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Hereditary Testing (Volume and Value) by Type
2.1.1 Global Hereditary Testing Consumption and Market Share by Type (2017-2022)
2.1.2 Global Hereditary Testing Revenue and Market Share by Type (2017-2022)
2.2 Global Hereditary Testing (Volume and Value) by Application
2.2.1 Global Hereditary Testing Consumption and Market Share by Application (2017-2022)
2.2.2 Global Hereditary Testing Revenue and Market Share by Application (2017-2022)
2.3 Global Hereditary Testing (Volume and Value) by Regions
2.3.1 Global Hereditary Testing Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Hereditary Testing Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Hereditary Testing Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Hereditary Testing Consumption by Regions (2017-2022)
4.2 North America Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
4.10 South America Hereditary Testing Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Hereditary Testing Market Analysis
5.1 North America Hereditary Testing Consumption and Value Analysis
5.1.1 North America Hereditary Testing Market Under COVID-19
5.2 North America Hereditary Testing Consumption Volume by Types
5.3 North America Hereditary Testing Consumption Structure by Application
5.4 North America Hereditary Testing Consumption by Top Countries
5.4.1 United States Hereditary Testing Consumption Volume from 2017 to 2022
5.4.2 Canada Hereditary Testing Consumption Volume from 2017 to 2022
5.4.3 Mexico Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 6 East Asia Hereditary Testing Market Analysis
6.1 East Asia Hereditary Testing Consumption and Value Analysis
6.1.1 East Asia Hereditary Testing Market Under COVID-19
6.2 East Asia Hereditary Testing Consumption Volume by Types
6.3 East Asia Hereditary Testing Consumption Structure by Application
6.4 East Asia Hereditary Testing Consumption by Top Countries
6.4.1 China Hereditary Testing Consumption Volume from 2017 to 2022
6.4.2 Japan Hereditary Testing Consumption Volume from 2017 to 2022
6.4.3 South Korea Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 7 Europe Hereditary Testing Market Analysis
7.1 Europe Hereditary Testing Consumption and Value Analysis
7.1.1 Europe Hereditary Testing Market Under COVID-19
7.2 Europe Hereditary Testing Consumption Volume by Types
7.3 Europe Hereditary Testing Consumption Structure by Application
7.4 Europe Hereditary Testing Consumption by Top Countries
7.4.1 Germany Hereditary Testing Consumption Volume from 2017 to 2022
7.4.2 UK Hereditary Testing Consumption Volume from 2017 to 2022
7.4.3 France Hereditary Testing Consumption Volume from 2017 to 2022
7.4.4 Italy Hereditary Testing Consumption Volume from 2017 to 2022
7.4.5 Russia Hereditary Testing Consumption Volume from 2017 to 2022
7.4.6 Spain Hereditary Testing Consumption Volume from 2017 to 2022
7.4.7 Netherlands Hereditary Testing Consumption Volume from 2017 to 2022
7.4.8 Switzerland Hereditary Testing Consumption Volume from 2017 to 2022
7.4.9 Poland Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 8 South Asia Hereditary Testing Market Analysis
8.1 South Asia Hereditary Testing Consumption and Value Analysis
8.1.1 South Asia Hereditary Testing Market Under COVID-19
8.2 South Asia Hereditary Testing Consumption Volume by Types
8.3 South Asia Hereditary Testing Consumption Structure by Application
8.4 South Asia Hereditary Testing Consumption by Top Countries
8.4.1 India Hereditary Testing Consumption Volume from 2017 to 2022
8.4.2 Pakistan Hereditary Testing Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Hereditary Testing Market Analysis
9.1 Southeast Asia Hereditary Testing Consumption and Value Analysis
9.1.1 Southeast Asia Hereditary Testing Market Under COVID-19
9.2 Southeast Asia Hereditary Testing Consumption Volume by Types
9.3 Southeast Asia Hereditary Testing Consumption Structure by Application
9.4 Southeast Asia Hereditary Testing Consumption by Top Countries
9.4.1 Indonesia Hereditary Testing Consumption Volume from 2017 to 2022
9.4.2 Thailand Hereditary Testing Consumption Volume from 2017 to 2022
9.4.3 Singapore Hereditary Testing Consumption Volume from 2017 to 2022
9.4.4 Malaysia Hereditary Testing Consumption Volume from 2017 to 2022
9.4.5 Philippines Hereditary Testing Consumption Volume from 2017 to 2022
9.4.6 Vietnam Hereditary Testing Consumption Volume from 2017 to 2022
9.4.7 Myanmar Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 10 Middle East Hereditary Testing Market Analysis
10.1 Middle East Hereditary Testing Consumption and Value Analysis
10.1.1 Middle East Hereditary Testing Market Under COVID-19
10.2 Middle East Hereditary Testing Consumption Volume by Types
10.3 Middle East Hereditary Testing Consumption Structure by Application
10.4 Middle East Hereditary Testing Consumption by Top Countries
10.4.1 Turkey Hereditary Testing Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Hereditary Testing Consumption Volume from 2017 to 2022
10.4.3 Iran Hereditary Testing Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Hereditary Testing Consumption Volume from 2017 to 2022
10.4.5 Israel Hereditary Testing Consumption Volume from 2017 to 2022
10.4.6 Iraq Hereditary Testing Consumption Volume from 2017 to 2022
10.4.7 Qatar Hereditary Testing Consumption Volume from 2017 to 2022
10.4.8 Kuwait Hereditary Testing Consumption Volume from 2017 to 2022
10.4.9 Oman Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 11 Africa Hereditary Testing Market Analysis
11.1 Africa Hereditary Testing Consumption and Value Analysis
11.1.1 Africa Hereditary Testing Market Under COVID-19
11.2 Africa Hereditary Testing Consumption Volume by Types
11.3 Africa Hereditary Testing Consumption Structure by Application
11.4 Africa Hereditary Testing Consumption by Top Countries
11.4.1 Nigeria Hereditary Testing Consumption Volume from 2017 to 2022
11.4.2 South Africa Hereditary Testing Consumption Volume from 2017 to 2022
11.4.3 Egypt Hereditary Testing Consumption Volume from 2017 to 2022
11.4.4 Algeria Hereditary Testing Consumption Volume from 2017 to 2022
11.4.5 Morocco Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 12 Oceania Hereditary Testing Market Analysis
12.1 Oceania Hereditary Testing Consumption and Value Analysis
12.2 Oceania Hereditary Testing Consumption Volume by Types
12.3 Oceania Hereditary Testing Consumption Structure by Application
12.4 Oceania Hereditary Testing Consumption by Top Countries
12.4.1 Australia Hereditary Testing Consumption Volume from 2017 to 2022
12.4.2 New Zealand Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 13 South America Hereditary Testing Market Analysis
13.1 South America Hereditary Testing Consumption and Value Analysis
13.1.1 South America Hereditary Testing Market Under COVID-19
13.2 South America Hereditary Testing Consumption Volume by Types
13.3 South America Hereditary Testing Consumption Structure by Application
13.4 South America Hereditary Testing Consumption Volume by Major Countries
13.4.1 Brazil Hereditary Testing Consumption Volume from 2017 to 2022
13.4.2 Argentina Hereditary Testing Consumption Volume from 2017 to 2022
13.4.3 Columbia Hereditary Testing Consumption Volume from 2017 to 2022
13.4.4 Chile Hereditary Testing Consumption Volume from 2017 to 2022
13.4.5 Venezuela Hereditary Testing Consumption Volume from 2017 to 2022
13.4.6 Peru Hereditary Testing Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Hereditary Testing Consumption Volume from 2017 to 2022
13.4.8 Ecuador Hereditary Testing Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Hereditary Testing Business
14.1 Myriad Genetics, Inc.
14.1.1 Myriad Genetics, Inc. Company Profile
14.1.2 Myriad Genetics, Inc. Hereditary Testing Product Specification
14.1.3 Myriad Genetics, Inc. Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 CooperSurgical, Inc.
14.2.1 CooperSurgical, Inc. Company Profile
14.2.2 CooperSurgical, Inc. Hereditary Testing Product Specification
14.2.3 CooperSurgical, Inc. Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Natera, Inc.
14.3.1 Natera, Inc. Company Profile
14.3.2 Natera, Inc. Hereditary Testing Product Specification
14.3.3 Natera, Inc. Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Invitae Corporation
14.4.1 Invitae Corporation Company Profile
14.4.2 Invitae Corporation Hereditary Testing Product Specification
14.4.3 Invitae Corporation Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Quest Diagnostics Incorporated
14.5.1 Quest Diagnostics Incorporated Company Profile
14.5.2 Quest Diagnostics Incorporated Hereditary Testing Product Specification
14.5.3 Quest Diagnostics Incorporated Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Illumina, Inc.
14.6.1 Illumina, Inc. Company Profile
14.6.2 Illumina, Inc. Hereditary Testing Product Specification
14.6.3 Illumina, Inc. Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Thermo Fisher Scientific, Inc.
14.7.1 Thermo Fisher Scientific, Inc. Company Profile
14.7.2 Thermo Fisher Scientific, Inc. Hereditary Testing Product Specification
14.7.3 Thermo Fisher Scientific, Inc. Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 F. Hoffmann-La Roche Ltd
14.8.1 F. Hoffmann-La Roche Ltd Company Profile
14.8.2 F. Hoffmann-La Roche Ltd Hereditary Testing Product Specification
14.8.3 F. Hoffmann-La Roche Ltd Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Laboratory Corporation of America Holdings
14.9.1 Laboratory Corporation of America Holdings Company Profile
14.9.2 Laboratory Corporation of America Holdings Hereditary Testing Product Specification
14.9.3 Laboratory Corporation of America Holdings Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Agilent Technologies, Inc.
14.10.1 Agilent Technologies, Inc. Company Profile
14.10.2 Agilent Technologies, Inc. Hereditary Testing Product Specification
14.10.3 Agilent Technologies, Inc. Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 CENTOGENE
14.11.1 CENTOGENE Company Profile
14.11.2 CENTOGENE Hereditary Testing Product Specification
14.11.3 CENTOGENE Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Twist Bioscience
14.12.1 Twist Bioscience Company Profile
14.12.2 Twist Bioscience Hereditary Testing Product Specification
14.12.3 Twist Bioscience Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Medgenome
14.13.1 Medgenome Company Profile
14.13.2 Medgenome Hereditary Testing Product Specification
14.13.3 Medgenome Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Sophia Genetics
14.14.1 Sophia Genetics Company Profile
14.14.2 Sophia Genetics Hereditary Testing Product Specification
14.14.3 Sophia Genetics Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Fulgent Genetic, Inc.
14.15.1 Fulgent Genetic, Inc. Company Profile
14.15.2 Fulgent Genetic, Inc. Hereditary Testing Product Specification
14.15.3 Fulgent Genetic, Inc. Hereditary Testing Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Hereditary Testing Market Forecast (2023-2028)
15.1 Global Hereditary Testing Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Hereditary Testing Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Hereditary Testing Value and Growth Rate Forecast (2023-2028)
15.2 Global Hereditary Testing Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Hereditary Testing Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Hereditary Testing Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Hereditary Testing Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Hereditary Testing Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Hereditary Testing Consumption Forecast by Type (2023-2028)
15.3.2 Global Hereditary Testing Revenue Forecast by Type (2023-2028)
15.3.3 Global Hereditary Testing Price Forecast by Type (2023-2028)
15.4 Global Hereditary Testing Consumption Volume Forecast by Application (2023-2028)
15.5 Hereditary Testing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 124 |
| Price : US$ 3500 |
Date : Nov 2024 |
| Category : Services |
Pages : 139 |
Request Sample 
Request Discount 
Inquire Before Buy
